These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35854422)

  • 21. Vaginal estrogen therapy in postmenopausal breast cancer patients treated with aromatase inhibitors.
    Moegele M; Buchholz S; Seitz S; Ortmann O
    Arch Gynecol Obstet; 2012 May; 285(5):1397-402. PubMed ID: 22212649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?
    Jones ME; Schoemaker MJ; Wright L; McFadden E; Griffin J; Thomas D; Hemming J; Wright K; Ashworth A; Swerdlow AJ
    Br J Cancer; 2016 Aug; 115(5):607-15. PubMed ID: 27467055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition.
    Bakken K; Fournier A; Lund E; Waaseth M; Dumeaux V; Clavel-Chapelon F; Fabre A; Hémon B; Rinaldi S; Chajes V; Slimani N; Allen NE; Reeves GK; Bingham S; Khaw KT; Olsen A; Tjønneland A; Rodriguez L; Sánchez MJ; Etxezarreta PA; Ardanaz E; Tormo MJ; Peeters PH; van Gils CH; Steffen A; Schulz M; Chang-Claude J; Kaaks R; Tumino R; Gallo V; Norat T; Riboli E; Panico S; Masala G; González CA; Berrino F
    Int J Cancer; 2011 Jan; 128(1):144-56. PubMed ID: 20232395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menopausal hormone therapy and breast cancer risk.
    Rozenberg S; Di Pietrantonio V; Vandromme J; Gilles C
    Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101577. PubMed ID: 34535397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Collaborative Group on Hormonal Factors in Breast Cancer
    Lancet; 2019 Sep; 394(10204):1159-1168. PubMed ID: 31474332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediagnostic use of menopausal hormone therapy and long-term survival of localized epithelial ovarian cancer: The Extreme study.
    Duus AH; Hannibal CG; Baandrup L; Zheng G; Galanakis M; Maltesen T; Hertzum-Larsen R; Mørch LS; Kjær SK
    Int J Cancer; 2024 Jul; 155(1):19-26. PubMed ID: 38532545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management.
    Trémollieres FA; André G; Letombe B; Barthélemy L; Pichard A; Gelas B; Lopès P
    Maturitas; 2022 Dec; 166():58-64. PubMed ID: 36058119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women.
    Wang X; Kapoor PM; Auer PL; Dennis J; Dunning AM; Wang Q; Lush M; Michailidou K; Bolla MK; Aronson KJ; Murphy RA; Brooks-Wilson A; Lee DG; Cordina-Duverger E; Guénel P; Truong T; Mulot C; Teras LR; Patel AV; Dossus L; Kaaks R; Hoppe R; Lo WY; Brüning T; Hamann U; Czene K; Gabrielson M; Hall P; Eriksson M; Jung A; Becher H; Couch FJ; Larson NL; Olson JE; Ruddy KJ; Giles GG; MacInnis RJ; Southey MC; Le Marchand L; Wilkens LR; Haiman CA; Olsson H; Augustinsson A; Krüger U; Wagner P; Scott C; Winham SJ; Vachon CM; Perou CM; Olshan AF; Troester MA; Hunter DJ; Eliassen HA; Tamimi RM; Brantley K; Andrulis IL; Figueroa J; Chanock SJ; Ahearn TU; García-Closas M; Evans GD; Newman WG; van Veen EM; Howell A; Wolk A; Håkansson N; Anton-Culver H; Ziogas A; Jones ME; Orr N; Schoemaker MJ; Swerdlow AJ; Kitahara CM; Linet M; Prentice RL; Easton DF; Milne RL; Kraft P; Chang-Claude J; Lindström S
    Sci Rep; 2022 Apr; 12(1):6199. PubMed ID: 35418701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Menopause hormone treatment after cancer.
    Gompel A
    Climacteric; 2023 Jun; 26(3):240-247. PubMed ID: 37011657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Menopausal hormonal therapy in surgically menopausal women with underlying endometriosis.
    Tanmahasamut P; Rattanachaiyanont M; Techatraisak K; Indhavivadhana S; Wongwananuruk T; Chantrapanichkul P
    Climacteric; 2022 Aug; 25(4):388-394. PubMed ID: 34783284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menopausal Hormone Therapy and Mortality: A Systematic Review and Meta-Analysis.
    Benkhadra K; Mohammed K; Al Nofal A; Carranza Leon BG; Alahdab F; Faubion S; Montori VM; Abu Dabrh AM; Zúñiga Hernández JA; Prokop LJ; Murad MH
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4021-8. PubMed ID: 26544652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menopausal hormone therapy and women's health: An umbrella review.
    Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
    PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Menopausal hormone therapy (MHT): refining our understanding of MHT research, optimally applying results, and considering the future of MHT.
    Anagnostis EA
    J Pharm Pract; 2012 Jun; 25(3):324-30. PubMed ID: 22550160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause.
    Staller K; Townsend MK; Khalili H; Mehta R; Grodstein F; Whitehead WE; Matthews CA; Kuo B; Chan AT
    Gastroenterology; 2017 Jun; 152(8):1915-1921.e1. PubMed ID: 28209529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.
    Trémollieres FA; Chabbert-Buffet N; Plu-Bureau G; Rousset-Jablonski C; Lecerf JM; Duclos M; Pouilles JM; Gosset A; Boutet G; Hocke C; Maris E; Hugon-Rodin J; Maitrot-Mantelet L; Robin G; André G; Hamdaoui N; Mathelin C; Lopes P; Graesslin O; Fritel X
    Maturitas; 2022 Sep; 163():62-81. PubMed ID: 35717745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis.
    Gu Y; Han F; Xue M; Wang M; Huang Y
    BMC Womens Health; 2024 Jan; 24(1):60. PubMed ID: 38263123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
    Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
    J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Menopausal Hormone Therapy and Risk for Parkinson's Disease.
    Yuk JS; Jeong SH
    J Parkinsons Dis; 2023; 13(8):1357-1367. PubMed ID: 37980684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries.
    Antoine C; Ameye L; Paesmans M; de Azambuja E; Rozenberg S
    Maturitas; 2016 Feb; 84():81-8. PubMed ID: 26654400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of menopausal hormone therapy on the risk of melanoma and keratinocyte skin cancer: A systematic review and meta-analysis of observational studies.
    Lallas K; Anagnostis P; Theocharis P; Boureka E; Kyrgidis A; Klonos E; Papazisis G; Apalla Z; Lallas A; Vakirlis E
    Maturitas; 2023 Feb; 168():20-28. PubMed ID: 36372010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.